Panion Animal Health AB (Publ):First trading day for series 2019 warrants
Panion Animal Health AB today announced that the first trading day of warrants of series 2019 will be July 12, 2018. One (1) warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 1.31 per share. Subscription of shares under the warrants shall be in accordance with the terms of the warrants during the period from September 1, 2019 through September 30, 2019.
Shares and share capital
The preferential share issue of units has been partly registered at the Swedish Companies Registration Office and the total number of shares amounts to 20 748 042 giving a share capital of SEK 966 939,224775.
Name: Panion Animal Health AB TO 2019
Short name: PANION TO 2
First day of trading: 12 July 2018
Last day of trading: 26 September 2019 Outstanding warrants of series 2019: 4 531 312
Anja E. H. Holm, CEO
+ 45-22 94 66 00
Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.
Panion is attracting interest from the agribusiness intelligence and animal health media Animal Pharm, where journalist Sian Lazell yesterday, 31.st of January 2019, noted the news on financing of the development program from Panion: https://bit.ly/2t1tgeK "Panion secures extra funding to back R&D. The financing round was carried out through the issuance of notes with warrants attached to Yorkville Advisors Global, that have a principal amount of SEK 100,000 each.
Panion Animal Health AB ("Panion") kallar på en andra tranche från den investeringsfond som förvaltas av Yorkville Advisors Global ("Yorkville").
Panion Animal Health AB ("Panion") draws down a second tranche from the investment fund managed by Yorkville Advisors Global ("Yorkville").
The rights issue in Panion Animal Health AB has been registered by the Swedish Companies Registration Office
The rights issue which was decided by the Board of Panion Animal Health AB, with the authorization of the Annual General Meeting of 29 May 2018, has now been registered by the Swedish Companies Registration Office. Shares and share capital after the registration by the Swedish Companies Registration Office amount to SEK 1,137,110.723254 divided into 24,399,487 shares.
Panion Animal Health AB
Marknadsplats: Spotlight Stock Market
Interim Report Q3 2018
2019-02-22 Delårsrapport Q4 2018